glp-1 discontinuation rates Weight maintenance after of therapies GLP-1 abandonment rates remain high

If symptoms persist beyond the early titration period, temporary dose stabilization or dose reduction should be considered

Additionally, it has been recommended to shorten follow-up periods for patients using a GLP-1 agonist for more frequent screenings (6 to 12 weeks), especially if DR is present or the patient reports vision loss since their last visit

Mar 16, 2026 Welcome to the 3rd Part of our 4 Part Series on GLP Medications in Physical Therapy

Delkhah explains

Wegovy, Ozempic and Semaglutide shots are the same medicine and its commonly referred to as GLP-1 injection or weight loss shots

Build a compliant D2C marketing engine (this is where weight loss clinics get hit hardest) Weight loss advertising is under more regulatory pressure than almost any other healthcare category